Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines

Vascular disease remains the leading cause of death and disability, the etiology of which often involves atherosclerosis. The current treatment of atherosclerosis by pharmacotherapy has limited therapeutic efficacy. Here we report a biomimetic drug delivery system derived from macrophage membrane co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Cheng, Huang, Qiaoxian, Liu, Conghui, Kwong, Cheryl H. T., Yue, Ludan, Wan, Jian-Bo, Lee, Simon M. Y., Wang, Ruibing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251120/
https://www.ncbi.nlm.nih.gov/pubmed/32457361
http://dx.doi.org/10.1038/s41467-020-16439-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251120/
https://www.ncbi.nlm.nih.gov/pubmed/32457361
http://dx.doi.org/10.1038/s41467-020-16439-7

Ejemplares similares